2012 Canadian Melanoma Conference

March 1 to 4, 2012
Rimrock Resort Hotel, Banff, Alberta

The Canadian Melanoma Conference is Canada's flagship meeting on the research and treatment of melanoma. It brings together Medical Oncologists, Surgeons, Dermatologists, Radiotherapists, Pathologists, Molecular Biologists, and Immunologists to review the latest evidence and explore new therapies.

Who should attend?

Medical Oncologists, Surgeons, Dermatologists, Radiotherapists, Pathologists, Molecular Biologists, Immunologists

Learning Objectives

• Communicate state-of-the-art knowledge in biology, pathogenesis, and melanoma pathology
• Review the biological basis of bRAF inhibition and the clinical implications in the management of melanoma
• Present pre-clinical and clinical research regarding MEK inhibition in melanoma
• Provide an update on the use of anti-CTLA4 therapy, including the evaluation of response and the management of immune-related toxicities
• Share novel research strategies and initiatives being conducted across Canada
• Identify new targets and targeted agents in the treatment of melanoma
• Review the multi-centre clinical trials currently open in Canada
• Identify key industry partners who would prioritize the development of products and programs in melanoma management in Canada
• Continue to build the network of basic and clinical investigators in order to promote translational and clinical research across Canada
• Discuss short- and long-term research strategies

Canadian Melanoma Conference
c/o BUKSA Strategic Conference Services
Suite 307, 10328 - 81 Avenue NW, Edmonton, AB T6E 1X2
Phone: 780.436.0983 ext. 234 Fax: 780.437.5984 Email:melanoma@buksa.com